Table 2 Total cohort screening history.
HCI | U of M | Penn | Total | |
|---|---|---|---|---|
Total cohort | ||||
Total subjects (n) | 100 | 95 | 68 | 263 |
Imaging screens (n) | 180 | 186 | 125 | 491 |
Screens per subject (mean ± SD) | 1.80 ± 1.17 | 1.96 ± 1.24 | 1.84 ± 1.23 | 1.87 ± 1.22 |
Range screens per subject (n) | 1–6 | 1–6 | 1–7 | 1–7 |
Screens including biochemistry (n [% screens]) | 117 (65%) | 135 (73%) | 91 (73%) | 343 (70%) |
Follow-up time, years (mean ± SD) | 1.58 ± 2.42 | 2.04 ± 2.69 | 1.82 ± 3.22 | 1.81 ± 2.75 |
Subjects with ≥2 screens (n [%]) | 44 (44%) | 47 (49%) | 32 (47%) | 123 (47%) |
Follow-up time, years (mean ± SD) | 3.60 ± 2.47 | 4.13 ± 2.45 | 3.86 ± 3.75 | 3.87 ± 2.86 |
Subjects with ≥3 screens (n [%]) | 20 (20%) | 24 (25%) | 15 (22%) | 59 (22%) |
Follow-up time, years (mean ± SD) | 5.22 ± 2.21 | 5.72 ± 2.34 | 5.53 ± 4.91 | 5.50 ± 3.17 |
No prior history of PGL/PCC | ||||
Subjects (n [% of total subjects]) | 83 | 59 | 52 | 194 (74%) |
Imaging screens (n [% of total screens]) | 149 | 98 | 87 | 334 (68%) |
Prior history of PGL/PCC | ||||
Subjects (n [% of total total]) | 17 | 36 | 16 | 69 (26%) |
Imaging screens (n [% of total screens]) | 31 | 88 | 38 | 157 (32%) |
